Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bodil Svennblad

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 26, 2021
Serum 25-hydroxyvitamin D is associated with fracture risk only during periods of seasonally high levels in women with a high body mass indexKarl Michaëlsson, Liisa Byberg, Bodil Svennblad, et al.
Journal of the American College of Cardiology|July 31, 2010
Eptifibatide is noninferior to abciximab in primary percutaneous coronary intervention: results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry)Axel Akerblom, Stefan K James, Michail Koutouzis, et al.
Cardiovascular Diabetology|January 16, 2015
Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational studyIrene Grundvold, Johan Bodegard, Peter M Nilsson, et al.
Pharmacoepidemiology and Drug Safety|December 17, 2022
Federated analyses of multiple data sources in drug safety studiesRolf Gedeborg, Wilmar Igl, Bodil Svennblad, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 4, 2017
Unfractionated heparin versus bivalirudin in patients undergoing primary percutaneous coronary intervention: a SWEDEHEART studyPer Grimfjärd, David Erlinge, Sasha Koul, et al.
The American Journal of Cardiology|July 14, 2022
Family History and Warning Symptoms Precede Sudden Cardiac Death in Arrhythmogenic Right Ventricular Cardiomyopathy (from a Nationwide Study in Sweden)Angelica Maria Delgado-Vega, Varvara Kommata, Bodil Svennblad, et al.
Journal of Hypertension|April 30, 2013
Blood pressure levels and risk of cardiovascular events and mortality in type-2 diabetes: cohort study of 34 009 primary care patientsJohan Sundström, Reza Sheikhi, Carl J Ostgren, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 11, 2017
Antithrombotic therapy after myocardial infarction in patients with atrial fibrillation undergoing percutaneous coronary interventionGorav Batra, Leif Friberg, David Erlinge, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|December 24, 2025
Long-Term Change in Vitamin D Status and its Association With Change in Total Hip Bone Mineral Density in Older Women: A Population-Based Cohort StudyKarl Michaëlsson, Håkan Melhus, Liisa Byberg, et al.
Diabetes Care|March 6, 2020
Early Childhood Antibiotic Treatment for Otitis Media and Other Respiratory Tract Infections Is Associated With Risk of Type 1 Diabetes: A Nationwide Register-Based Study With Sibling AnalysisMona-Lisa Wernroth, Katja Fall, Bodil Svennblad, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 26, 2021
Serum 25-hydroxyvitamin D is associated with fracture risk only during periods of seasonally high levels in women with a high body mass indexKarl Michaëlsson, Liisa Byberg, Bodil Svennblad, et al.
Journal of the American College of Cardiology|July 31, 2010
Eptifibatide is noninferior to abciximab in primary percutaneous coronary intervention: results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry)Axel Akerblom, Stefan K James, Michail Koutouzis, et al.
Cardiovascular Diabetology|January 16, 2015
Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational studyIrene Grundvold, Johan Bodegard, Peter M Nilsson, et al.
Pharmacoepidemiology and Drug Safety|December 17, 2022
Federated analyses of multiple data sources in drug safety studiesRolf Gedeborg, Wilmar Igl, Bodil Svennblad, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 4, 2017
Unfractionated heparin versus bivalirudin in patients undergoing primary percutaneous coronary intervention: a SWEDEHEART studyPer Grimfjärd, David Erlinge, Sasha Koul, et al.
The American Journal of Cardiology|July 14, 2022
Family History and Warning Symptoms Precede Sudden Cardiac Death in Arrhythmogenic Right Ventricular Cardiomyopathy (from a Nationwide Study in Sweden)Angelica Maria Delgado-Vega, Varvara Kommata, Bodil Svennblad, et al.
Journal of Hypertension|April 30, 2013
Blood pressure levels and risk of cardiovascular events and mortality in type-2 diabetes: cohort study of 34 009 primary care patientsJohan Sundström, Reza Sheikhi, Carl J Ostgren, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 11, 2017
Antithrombotic therapy after myocardial infarction in patients with atrial fibrillation undergoing percutaneous coronary interventionGorav Batra, Leif Friberg, David Erlinge, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|December 24, 2025
Long-Term Change in Vitamin D Status and its Association With Change in Total Hip Bone Mineral Density in Older Women: A Population-Based Cohort StudyKarl Michaëlsson, Håkan Melhus, Liisa Byberg, et al.
Diabetes Care|March 6, 2020
Early Childhood Antibiotic Treatment for Otitis Media and Other Respiratory Tract Infections Is Associated With Risk of Type 1 Diabetes: A Nationwide Register-Based Study With Sibling AnalysisMona-Lisa Wernroth, Katja Fall, Bodil Svennblad, et al.
Pageof 6